facebook

The Established Safety of AFSTYLA

AFSTYLA safety was evaluated in the largest FVIII clinical trial to date with 258 participants

ZERO INHIBITORS

ZERO inhibitors were observed in 258 previously treated children, adolescents, and adults over 19,545 exposure days.

14 of 258 participants reported a side effect

One person withdrew due to a side effect (allergic reaction).

Most common side effects

SIDE EFFECTS

Get your free AFSTYLA Discovery Kit

Sign up today!

Sign-up now
You are now leaving the current website.

Do you want to continue?

No Yes